Senator Collins, Representative Eshoo decry Medicare coverage rejection of Alzheimer’s drugs

UsAgainstAlzheimer’s

18 October 2022 - “It’s not CMS’ job to deny the use under the Medicare program of an FDA-approved drug.” – Sen. Susan Collins; “…breakthroughs have to reach people, otherwise it really doesn’t mean a darn thing to them.” – Rep. Anna Eshoo.

During UsAgainstAlzheimer’s 2022 National Summit, members of Congress, scientists, and other leaders spoke out against the Centers for Medicare and Medicaid Services decision to deny Medicare coverage of FDA approved Alzheimer’s treatments.

Read UsAgainstAlzheimer's press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Medicare , Funding